David Jaroslaw

David Jaroslaw provides product liability advice and litigates on behalf of manufacturers in various industries, including the tobacco, vape product, and wellness sectors, in the US, Europe, and Asia. He specializes in the translation of complex scientific, medical, and technological issues into effective advocacy for life science industry clients. He has litigated a broad spectrum of complex civil and criminal matters in both federal and state courts, at the pre-trial, trial, and appellate level.

Prior to coming to Rimon, David was an associate at Paul, Weiss, Rifkind, Wharton & Garrison, and a partner at Jacob, Medinger & Finnegan; Greenspoon Marder; and DLA Piper. At these firms, he litigated and advised clients in relation to a variety of complex product liability and commercial litigation matters, often with an international component. In addition, David prosecuted organized crime and international money laundering for the Rackets Bureau of the New York County District Attorney’s Office and for the New York State Organized Crime Task Force (where he was also cross-designated as a Special Assistant United States Attorney). David investigated and prosecuted a money laundering ring involving international drug sellers, major import/export companies and US investment banks, and led the prosecution of the leadership of the plumbers’ union. 

SPEAKING ENGAGEMENTS

• Speaker, “Vaping and COVID 19 — Plausibility and Causation,” DRI Seminar, January 2021 
• Speaker, “Vaping: Tobacco Litigation 2.0,” 2020 Federation of Defense and Corporate Counsel Winter Meeting, March 2020 
• Speaker, “Up in Smoke,” 2018 Federation of Defense and Corporate Counsel Annual Meeting, August 2018 
• Speaker, “Across Town by App,” Federation of Defense and Corporate Counsel Annual Meeting, July 2016 

PUBLICATIONS

• Author, “Vaping and COVID 19 — Plausibility and Causation,” DRI Seminar Paper, January 2021 
• Author, “CBD Product Liability Issues — Taking Proactive Steps to Mitigate Risk,” Cortex — DLA Piper Life Sciences Insights, November 2020 
• Author, “Cryptocurrency and Blockchain: Hitting the Real World and Some Real World Problems,” Financier Worldwide, May 2019 
• Author, “IP in the Cannabis Industry: Where Laws Collide,” FDCC Insights, March 2018 
• Author, “Next Move? Your Post-Deeming Strategy Starts with A Proper Understanding of the FDA’s New Rules,” Tobacco Reporter, August 2016 
• Author, “Across Town by App,” FDCC Annual Meeting, July 2016 

AWARDS AND RECOGNITION

• The Legal 500 United States – Recommended, Product Liability, Mass Tort and Class Action: Consumer Products (including Tobacco), 2021
• The Legal 500 United States – Recommended, Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices – Defense, 2021

MEMBERSHIPS

• Federation of Defense and Corporate Counsel, Intellectual Property, Science, and Technology Section, Chair 
• New York City Bar Association  
• American Bar Association 

CIVIC AND CHARITABLE

• Brooklyn Heights Synagogue, Past President, 2016-2018; Board of Trustees, 2005-Present
• Union of Reform Judaism Eisner and Crane Lake Camps, Chair, Nominating Committee; Board of Advisors, 2011-2019